Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants

Completed

Conditions studied: Patent Ductus Arteriosus

In brief

This is a retrospective chart review to look at the timing of using indomethacin and ibuprofen for PDA closure for infants admitted into the NICU of the University of Utah Hospital from 1/2007-8/2008. The purpose is to compare the outcomes of medical intervention in preterm infants if intervention occurs day of life 4 or less, or day of life 5 or greater, with the birthdate being counted as day of life 1.

Key facts

Study ID

NCT00795990

Run by

University of Utah

People needed

350

Starts

2008-11-01

Expected to finish

2014-11-01

Last updated by the study team

2014-12-05

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• birth weight less than 1200 gm

You may not qualify if…

• none

Where it is running

• University of Utah — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.